0.30 | 0.58%
| Price and Volume | |
|---|---|
| Recent Price | 52.26 |
| 52 Week High | 63.53 |
| 52 Week Low | 51.20 |
| Avg. Daily Vol. (Mil) | 2.33 |
| Beta (3 year) | 0.53 |
| Share Related Items | |
| Mkt Cap (Mil) | 126,589.40 |
| Shares Out (Mil) | 2,422.30 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 4.70 |
| Annual Dividend | 2.48 |
| Payout Ratio | 70.00 |
| Financial Strength | |
| Quick Ratio | 0.60 |
| Current Ratio | 0.90 |
| LT Debt/ Equity | 0.22 |
| Total Debt / Equity | 0.39 |
| Valuation Ratios | |
| Price Earnings | 14.70 |
| Price/Sales | 2.14 |
| Price/Book | 2.01 |
| Price/Cash Flow | 14.50 |
| Per Share Data | |
| Earnings | 3.55 |
| Sales | 24.38 |
| Book Value | 26.05 |
| Cash Flow | 3.60 |
| Business Summary | |
|---|---|
| Novartis AG provides healthcare solutions that address the evolving needs of patients & societies worldwide with a portfolio that includes innovative medicines, preventive vaccines & diagnostic tools, generic pharmaceuticals & consumer health products. | |
| General Information | |
| Lichtstrasse 35
Basel, 4056 |
|
| 1.0 | |
| www.novartis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 124000 | |
| CEO: Joseph Jimenez | |
| Short Interest | |
| Current Month (Mil) | 3.20 |
| Previous Month (Mil) | 3.50 |
| Short Interest Ratio (Days) | 1.40 |
| Management Effectiveness | |
| Return on Equity | 13.90 |
| Return on Assets | 7.40 |
| Return on Investments | 11.40 |
| Profitability | |
| Gross Margin | 67.70 |
| EBIT Margin | 18.40 |
| Profit Margin | 14.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.79
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet